From the registry it follows that the use of the drug for medical use "is possible only in a hospital."

As noted in R-Pharm, the production of the drug was organized with the participation of the Industrial Development Fund and will be carried out in Yaroslavl.

In June, Vladimir Kolyshkin, director of the Yaroslavl finished dosage form plant, announced that Coronavir would hit the market in early July.